Meeting opening – O. Caffo – G. Malossini |
|
Opening lecture: High risk and metastatic prostate cancer patients: the added value of the multidisciplinary management – R. Valdagni | |
First session: high risk localized disease |
|
Clinical case and evidences from literature – U. Basso | |
Expert opinion – A. Bossi, A. Lapini | |
Attendants involvement in the discussion – Provokers: N. Mottet, G. Pappagallo, F. Demichelis | |
Second session: metastatic hormone sensitive prostate cancer |
|
Clinical case and evidences from literature – M. Tucci | |
Expert opinion – R. De Wit – A. Lapini | |
Attendants involvement in the discussion – Provokers: N. Mottet, G. Pappagallo, F. Demichelis | |
Closing remarks | |
Third session: mCRPC first line |
|
Clinical case and evidences from literature – C. Ortega (Substitute: R. Iacovelli) |
|
Expert opinion – B. Tombal – S. Bracarda | |
Attendants involvement in the discussion – Provokers: N. Mottet, G. Pappagallo, F. Demichelis | |
Fourth session: mCRPC further lines |
|
Clinical case and evidences from literature – R. Iacovelli | |
Expert opinion – Silke Gillessen, G. Procopio | |
Attendants involvement in the discussion – Provokers: N. Mottet, G. Pappagallo, F. Demichelis | |
Meeting closing – O. Caffo – G. Malossini |